CliffBio
small molecule

ARICEPT

DONEPEZIL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyEisai →See this company's full patent-cliff portfolio

Drug detail

Brand nameARICEPT
Active ingredientDONEPEZIL HYDROCHLORIDE
Strength5MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2004
Marketing statusDISCN

More from Eisai

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ARICEPT patent cliff — loss of exclusivity — | CliffBio